FDA Inspection 1278407 — Arthrex Inland Empire

Arthrex Inland Empire — FEI 3006228878

The FDA completed an inspection of Arthrex Inland Empire on August 6, 2025 in Corona, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 6, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Corona, CA (United States)